These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20060632)

  • 21. Wolfson Foundation's policy on animals angers other British medical charities.
    Dickson D
    Nature; 1993 May; 363(6424):4-5. PubMed ID: 8379990
    [No Abstract]   [Full Text] [Related]  

  • 22. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
    KDOQI
    Am J Kidney Dis; 2007 Feb; 49(2 Suppl 2):S12-154. PubMed ID: 17276798
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.
    Johnson CA; Levey AS; Coresh J; Levin A; Lau J; Eknoyan G
    Am Fam Physician; 2004 Sep; 70(6):1091-7. PubMed ID: 15456118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. North Carolina Medical Society Foundation's Community Practitioner Program.
    Seligson RW; Highsmith PP
    N C Med J; 2006; 67(1):83-5. PubMed ID: 16550997
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AONE Foundation Embarks on New Initiatives.
    Begley R
    J Nurs Adm; 2018; 48(7-8):358-360. PubMed ID: 30028812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary.
    Whaley-Connell AT; Vassalotti JA; Collins AJ; Chen SC; McCullough PA
    Am J Kidney Dis; 2012 Mar; 59(3 Suppl 2):S1-4. PubMed ID: 22339897
    [No Abstract]   [Full Text] [Related]  

  • 28. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R; Kalantar-Zadeh K
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caring for the elderly chronically ill: a foundation's perspective.
    Cluff LE; Merrill JC
    J Ambul Care Manage; 1990 May; 13(2):53-8. PubMed ID: 10113145
    [No Abstract]   [Full Text] [Related]  

  • 30. Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis.
    Khanna D; Arnold EL; Pencharz JN; Grossman JM; Traina SB; Lal A; MacLean CH
    Semin Arthritis Rheum; 2006 Feb; 35(4):211-37. PubMed ID: 16461068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).
    Whaley-Connell A; Kurella Tamura M; McCullough PA
    Am J Kidney Dis; 2012 Nov; 60(5):692-3. PubMed ID: 23067631
    [No Abstract]   [Full Text] [Related]  

  • 33. The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD.
    Nelson RG; Tuttle KR
    Blood Purif; 2007; 25(1):112-4. PubMed ID: 17170547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pfizer Foundation's Community Health Ventures program: providing models for community health partnerships.
    Roan C; Clark CW
    Health Aff (Millwood); 2002; 21(6):250-4. PubMed ID: 12442863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing bone parameters in dialysis patients: international guideline conflicts.
    Faull RJ
    Semin Dial; 2007; 20(3):191-4. PubMed ID: 17555479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing for chronic kidney disease: a position statement from the National Kidney Foundation.
    Vassalotti JA; Stevens LA; Levey AS
    Am J Kidney Dis; 2007 Aug; 50(2):169-80. PubMed ID: 17660017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The California Wellness Foundation's grant making in work and health.
    Brousseau R; Peña LC
    Health Aff (Millwood); 2002; 21(2):274-80. PubMed ID: 11900169
    [No Abstract]   [Full Text] [Related]  

  • 38. A critique of clinical guidelines for detection of individuals with chronic kidney disease.
    Connolly JO; Woolfson RG
    Nephron Clin Pract; 2009; 111(1):c69-73. PubMed ID: 19060500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
    Nogueira J; Weir M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey.
    Agrawal V; Ghosh AK; Barnes MA; McCullough PA
    Am J Kidney Dis; 2008 Dec; 52(6):1061-9. PubMed ID: 18976845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.